Watch this webinar to learn why many major pharma organizations are investing in QSP for its potential to improve pharma R&D productivity.
Watch this webinar to learn how RSABE for NTIDs can be performed in Phoenix WinNonlin using a reusable template.
This webinar focused on the impact of RI on substrates of organic cation transporter 2 (OCT2), one of the major renal transporters which has been shown to be affected—both in activity and expression—in RI in pre-clinical species and in vitro systems.
Application of Tracer Kinetics in Drug Development: A Valuable but Underused Tool in Clinical Pharmacology
In this webinar, Pau Aceves, Associate Director of Consulting Services at Certara, presented case studies on how tracer kinetics were used to inform development of new drugs for lung, CNS, and liver diseases. By watching this webinar, you will learn how tracer kinetics can leveraged for PK, PD, and in silico modeling applications.
This webinar introduced how IVIVC can be used to get your drug program back on track! Learn how to analyze a failed BE study and use IVIVC to explore better dissolution tests, predict your target dissolution to meet the reference, and optimize your drug’s formulation.
In this webinar, Sebastian Polak, Nikunj Patel, and Mark Holbrook introduced the Cardiac Safety Simulator (CSS) platform and explained how they developed a QSTS model for citalopram to serve as a “virtual twin” and help predict the likely occurrence of cardiotoxic events in real patients under different clinical conditions.
In this webinar, Noreen Muscat from QACV Consulting discussed common pitfalls in validation and how to avoid them, and Allan Michaels, Sr. Project Manager of Phoenix Technology Services, shared how the latest Validation Suite for Phoenix WinNonlin expedites validation and provides robust reporting.
As the gold standard for PK/PD software, our upcoming Phoenix 8.1 release delivers new capabilities to automate processes, reduce errors, and save you time. Dr. Nathan Teuscher, VP of Pharmacometric Consulting, Venkateswari Muthukrishnan, Phoenix WinNonlin Product Manager, and Ana Henry, Executive Director of Training, shared our latest innovations in WinNonlin and NLME and conducted a live demo.
This webinar introduced the importance of bioanalysis and its downstream effects on clinical development and clinical pharmacology.
David Lowis described a case study where D360 was used to replace older technologies at a biotechnology company. He also showed D360’s new visualization tools and shares the future roadmap as D360 advances its support of biologics in addition to small molecules.